# Challenging Additivity: Comparing Predicted and Observed AhR Activity of Polycyclic Aromatic Compound (PAC) Mixtures Containing Active and Inactive Constituents

**Authors:** Kristin M. Eccles, Kimberly Gaston, Emily M. Green, Suramya Waidyanatha, Billie Stiffler, Shawn F. Harris, Cynthia V. Rider, Elizabeth Medlock Kakaley

PMC · DOI: 10.1021/acs.est.5c11914 · 2026-01-21

## TL;DR

This study compares predicted and observed toxicity of PAC mixtures using different models, finding that including inactive chemicals overestimates potency.

## Contribution

The study introduces a framework for modeling PAC mixtures by prioritizing active components and using BMC-based methods.

## Key findings

- Including inactive chemicals in mixture models leads to overestimation of potency.
- Generalized concentration addition (GCA) paired with BMC10 modeling provides the best agreement with observed responses.
- Scaling contributions to active components improves predictive accuracy.

## Abstract

Class-based cumulative risk assessment approaches have
been applied
to high-priority environmental contaminants such as polycyclic aromatic
compounds (PACs), yet uncertainties remain in their application. In
this study, we evaluated the influence of inactive chemicals on mixture
modeling outcomes and explored strategies for predicting the aryl
hydrocarbon receptor (AhR)-mediated toxicity of PAC mixtures. Using
an in vitro AhR reporter gene assay, we tested seven defined mixtures
composed of six active and seven inactive PACs. Observed concentration–response
curves were compared to predictions from three established mixture
models, concentration addition (CA), independent action (IA), and
generalized concentration addition (GCA), using both effective concentration
eliciting 10% response (EC10) and benchmark concentration (BMC10) approaches. Including inactive chemicals without scaling
led to consistent overestimation of potency, especially in models
assuming equal efficacy. Predictive accuracy improved across all models
when mixtures were limited to active chemicals and contributions were
scaled to 100%, excluding inactives. Among approaches, GCA consistently
produced the best agreement with measured responses, particularly
when paired with BMC modeling. BMC10 values better accommodate partial
agonists. Our findings support a pragmatic, mechanism-based framework
for modeling environmental mixtures, one that prioritizes active components,
scales their contributions, and adopts BMC-based methods to estimate
potency.

## Linked entities

- **Proteins:** AHR (aryl hydrocarbon receptor)

## Full-text entities

- **Genes:** Cse1l (chromosome segregation 1 like) [NCBI Gene 110750] {aka 2610100P18Rik, Capts, Cas, Xpo2}, Xpo1 (exportin 1) [NCBI Gene 103573] {aka Crm1, Exp1}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 403464], AHR (aryl hydrocarbon receptor) [NCBI Gene 475251], Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}
- **Diseases:** lung tissue damage (MESH:D055370), CA (MESH:C567712), reproductive toxicity (MESH:D060737), carcinogenic (MESH:D011230), PACs (MESH:D005597), cytotoxic (MESH:D064420), liver tumor (MESH:D008113), cancer (MESH:D009369), craniofacial and cardiac malformations (MESH:D006331), cardiotoxicity (MESH:D066126)
- **Chemicals:** chrysene (MESH:C031180), benzo[a]pyrene (MESH:D001564), pyrene (MESH:C030984), sulfur (MESH:D013455), benzo[c]fluorene (MESH:C041513), BMC10 (-), phenanthrene (MESH:C031181), benz[j]aceanthrylene (MESH:C037411), acenaphthenequinone (MESH:C023722), benzo[k]fluoranthene (MESH:C022921), dibenzothiophene (MESH:C016366), indeno[1,2,3-cd]pyrene (MESH:C041508), Dibenz[a,h]anthracene (MESH:C026486), staurosporine (MESH:D019311), DMSO (MESH:D004121), dibenzo[a,l]pyrene (MESH:C041517), water (MESH:D014867), CO2 (MESH:D002245), benzo[b]fluoranthene (MESH:C006703)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** EC10 — Mus musculus (Mouse), Hybridoma (CVCL_C4R4), BMC10 — Mus musculus (Mouse), Transformed cell line (CVCL_2I36)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12874505/full.md

---
Source: https://tomesphere.com/paper/PMC12874505